
Revelar provides noninvasive breath tests to detect diseases and tailor treatments. It uses the Aldehyde Reveal breath test and combines clinical evidence with deep data analysis to identify by-products of free radical damage. This healthcare diagnostics platform integrates with clinical workflows and targets providers, labs, and researchers. The approach aims to reduce diagnostic delays and personalize therapy at scale in the healthcare market.

Revelar provides noninvasive breath tests to detect diseases and tailor treatments. It uses the Aldehyde Reveal breath test and combines clinical evidence with deep data analysis to identify by-products of free radical damage. This healthcare diagnostics platform integrates with clinical workflows and targets providers, labs, and researchers. The approach aims to reduce diagnostic delays and personalize therapy at scale in the healthcare market.